Overview
The GSDS-T was developed by Lee KA to assess difficulty falling asleep, waking up during sleep, sleep quality, and daytime alertnes. The Turkish validity and reliability of the scale have been conducted on stroke patients but not on multiple sclerosis patients. The aim of this study is to investigate the validity and reliability of the Turkish version of general sleep disturbance scale (GSDS-T) in patients with multiple sclerosis
Description
The GSDS-T was developed by Lee KA to assess difficulty falling asleep, waking up during sleep, sleep quality, and daytime alertnes. The Turkish validity and reliability of the scale has been conducted on stroke patients but not on multiple sclerosis patients. The aim of this study is to investigate the validity and reliability of the Turkish version of general sleep disturbance scale (GSDS-T) in patients with multiple sclerosis. GSD has 21 questions. This study will be conducted on patients with multiple sclerosis (MS). 126 participants will be included in the study. In order to evaluate the validity of the GSDS-T, the Pittsburgh Sleep Quality Index (PSQI) which can evaluate sleep quality and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.
Eligibility
Inclusion Criteria:
- Individuals over the age of 18 who have been diagnosed with Multiple Sclerosis for at least two years,
- Those with an EDSS score >2.
- Those without symptoms of insomnia according to the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) diagnostic criteria
- Individuals whose native language is Turkish and who have the ability to speak and understand.
Exclusion Criteria:
- Those with severe spasticity,
- Those with vision and hearing problems,
- Those with a known mental illness (major depression, schizophrenia, psychosis, etc.),
- Those in an acute relapse phase,
- Those using dietary supplements,
- Those using tranquilizers or immunosuppressants.